We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Anna MacDonald

Anna MacDonald profile page

Senior Science Editor

 at Technology Networks


After obtaining a first-class honors degree in biological sciences from the University of East Anglia, Anna worked as a scientific conference producer before joining Technology Networks. As part of her role, Anna helps to coordinate coverage, working with key opinion leaders from industry and academia to produce content across all communities.


Education


University of East Anglia  


Areas of Expertise



Got a Question for Anna MacDonald?


Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 318
Therapeutic drugs next to a stethoscope and target with a dart in the bullseye.
Industry Insight

Expanding the Druggable Space With Degradation-Based Therapies

We spoke with Dr. Christian Dillon to learn more about degradation-based therapies, the challenges associated with their discovery and how innovative solutions are helping to realize the potential of this promising class of therapeutics.
Snippet of the cell culture quality control infographic.
Infographic

Cell Culture Quality Control

Download this infographic to explore why quality control is key, the importance of cell line authenticity and how to reduce the risk of microbial contamination.
Close up view of the cathode end of a group of batteries.
Industry Insight

Improving Battery Analysis With Simultaneous Rheology and Impedance Measurements

Sarah Cotts tells us more about the Rheo-Impedance accessory and how it can help overcome limitations with current analysis approaches to improve battery development.

Dr. Sarah Teichmann standing next to a building and pond.
Article

From School Science Club to Cell Atlasing With Dr. Sarah Teichmann

In this interview, Dr. Sarah Teichmann shares insights into her research interests, the goals and progress of the HCA to date, as well as her thoughts on how women can begin and build successful careers in science.
Ribosome translating mRNA into a polypeptide chain.
Industry Insight

Tuning the Therapeutic Properties of tRNAs To Treat Rare Diseases

Michelle C. Werner discusses how tRNAs could transform the drug development paradigm from gene-centric to gene-agnostic and accelerate new therapies for 30 million or more patients whose genetically driven disease can be classified under Stop Codon Disease.
Schematic representation of SemaCyte microcarriers including optical barcodes.
Industry Insight

Tackling Unmet Drug Screening Needs

In this interview, Jeroen Verheyen tells us about Semarion, its SemaCyte technology and how it can help to address unmet drug screening needs.
Oak tree on a white background.
Industry Insight

Sequencing Life To Conserve Biodiversity

Neil Ward tells us about the role that genomics can play in conserving biodiversity and how innovative technologies such as HiFi sequencing are helping biodiversity projects.
Strand of orange mRNA on a blue background.
Industry Insight

Harnessing the Therapeutic Potential of Circular RNA

In this interview, Erik Digman Wiklund tells us about the discovery of circRNA and discusses some of the challenges of harnessing its full potential for therapeutic interventions.
Snippet of the lab water purification infographic.
Infographic

Lab Water Purification

Download this infographic to explore why water purity is important and how water purity is defined.
Orange and black electric car plugged into a charging point in a car park.
Industry Insight

Revolutionizing EV Battery Production: Silane's Impact on Silicon-Anode Advancements

Technology Networks recently connected with Vincent Pluvinage, CEO of OneD Battery Sciences, and George Schlowsky, president of Koch Modular, to shed light on the advancements of anode technology within the EV battery industry.
Advertisement